Men most likely to exhibit the worst COVID-19 symptoms, according to a new study
April 30, 2020Business Services COVID-19, coronavirus
Research into coronavirus cases in Shenzhen, China found that men were 2.5 times as likely to exhibit severe symptoms. The …
Arizona GOP lawmakers and AAPS say hydroxychloroquine has 90% chance of helping COVID-19 patients, but data is not based on clinical trials
April 29, 2020Research and Development chloroquine, hydroxychloroquine
The Association of American Physicians and Surgeons (AAPS) wrote a letter to Republican Arizona Governor Doug Ducey urging the wider …
Phase 3 Libtayo monotherapy trial halted early due to strong benefit in advanced non-small cell lung cancer
April 29, 2020Research and Development Cancer, Libtayo, Regeneron, Sanofi, lung cancer
A Phase 3 study of Sanofi and Regeneron’s Libtayo (cemiplimab) as a monotherapy for advanced or metastatic non-small cell lung …
Australia calls for investigation into China’s coronavirus response
April 29, 2020Research and Development Australia, COVID-19, China, coronavirus
Scott Morrison, the Australian Prime Minister, has called for an investigation into the origins of the COVID-19 coronavirus, as Australia …
Pharmafile.com’s weekly COVID-19 news round-up
April 29, 2020Research and Development BARDA, COVID-19, coronavirus, hydroxychloroquine
Hydroxychloroquine continues to feature in coronavirus news. Rick Bright, the Director of BARDA, alleges he was pushed out of his …
EU approval for Novartis’ Cosentyx in active non-radiographic axial spondyloarthritis
April 29, 2020Research and Development, Sales and Marketing Cosentyx, EU, Novartis, axial spondyloarthritis, pharma
Novartis has revealed that the European Commission has moved to approve Cosentyx (secukinumab) for the treatment of active non-radiographic axial …
Nearly half of Americans believe COVID-19 was created in a lab, according to a new survey
April 28, 2020Manufacturing and Production COVID-19, coronavirus, survey
Almost half of Americans believe that the coronavirus was created in a lab, according to an April survey of 6,300 …
The May 2020 issue of Pharmafocus is available to read free online now!
April 28, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma
The latest monthly edition of Pharmafocus, the May 2020 issue, is available to read for free online now!
NICE backtracks to approve Janssen’s Stelara in ulcerative colitis
April 28, 2020Manufacturing and Production, Research and Development Janssen, NICE, Stelara, ulcerative colitis
NICE has recommended Janssen’s Stelara (ustekinumab) for the treatment of moderately to severely active ulcerative colitis (UC), a move which …
South Korean researchers start testing pancreatitis drug in COVID-19 patients
April 28, 2020Manufacturing and Production COVID-19, Pancreas, Pancreatitis, coronavirus
The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 …
12 British children hospitalised with rare condition linked to COVID-19
April 28, 2020Manufacturing and Production COVID-19, NHS, NHS UK, coronavirus
12 children have fallen ill across the UK with a new and potentially fatal combination of symptoms linked to COVID-19. …
Reinventing the value equation
April 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, feature, real world data, real world evidence, real-world data, real-world evidence
There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …
Sanofi’s Meningococcal Conjugate Vaccine secures FDA approval in patients aged two and up
April 27, 2020Sales and Marketing FDA, MenQuadfi, Sanofi, US, meningococcal disease, pharma
Sanofi’s MedQuadfi Meningococcal Conjugate Vaccine has scored FDA approval for the prevention of invasive meningococcal disease, becoming the first and …
Italy to relax COVID-19 lockdown in early May
April 27, 2020Sales and Marketing COVID-19, COVID-19 coronavirus, Italy, coronavirus
Italy has outlined its plans to ease the lockdown restrictions that were implemented across the country 7 weeks ago to …
Researchers studying heartburn drug as potential coronavirus treatment
April 27, 2020Sales and Marketing COVID-19, Pepcid, coronavirus, pandemic
Researchers in America have been studying famotidine, the active ingredient in Pepcid, as a potential treatment for COVID-19. Pepcid is …
‘Excess deaths’ in England among the highest in Europe
April 27, 2020Sales and Marketing COVID-19, coronavirus, deaths, pandemic
English excess deaths from the coronavirus are comparable to the worst hit countries in Europe, according to a Sky News …
FDA urges close monitoring of COVID-19 patients treated with hydroxychloroquine
April 27, 2020Sales and Marketing COVID-19, FDA, chloroquine, coronavirus, hydroxychloroquine
The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated …
European Medicines Agency’s review of Picato finds its risks outweigh its benefits
April 24, 2020Business Services, Medical Communications, Sales and Marketing
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high …
Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial
April 24, 2020Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …
Top Ten most popular articles on Pharmafile.com this week
April 24, 2020Medical Communications COVID-19, coronavirus, top 10
Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
